Name: UMIN ID:
Unique ID issued by UMIN | UMIN000009523 |
---|---|
Receipt number | R000010766 |
Scientific Title | Plasma Exchange and glucocorticoids in anti-neutrophil cytoplasm antibody associated vasculitis: a randomized controlled trial. PEXIVAS |
Date of disclosure of the study information | 2012/12/11 |
Last modified on | 2020/02/16 12:51:31 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/12/11 16:14:03 | ||
2 | Update | 2012/12/11 16:19:07 | Date of disclosure of the study information |
|
3 | Update | 2012/12/11 16:22:29 | Date of disclosure of the study information |
|
4 | Update | 2012/12/11 16:57:08 | Division name |
|
5 | Update | 2012/12/17 13:52:08 | Email |
|
6 | Update | 2013/02/20 12:35:52 | Recruitment status |
|
7 | Update | 2013/04/30 13:31:37 | Organization3 Address3 Tel3 Email3 Institutions |
|
8 | Update | 2013/04/30 13:40:50 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
9 | Update | 2013/04/30 13:41:45 | Condition |
|
10 | Update | 2013/04/30 13:44:58 | Division name Division name |
|
11 | Update | 2013/04/30 14:06:52 | Public title |
|
12 | Update | 2013/08/08 16:50:50 | Institutions |
|
13 | Update | 2015/03/04 14:28:04 | Target sample size |
|
14 | Update | 2015/03/04 14:34:25 | Email Name of secondary funder(s) Name of secondary funder(s) Institutions |
|
15 | Update | 2015/03/04 14:39:53 | Last follow-up date Other related information Other related information |
|
16 | Update | 2015/03/04 14:57:41 | Co-sponsor |
|
17 | Update | 2015/06/11 16:00:01 | Other related information Other related information |
|
18 | Update | 2015/12/18 18:46:07 | Other related information Other related information |
|
19 | Update | 2016/07/15 16:33:44 | Name of primary person or sponsor Organization Email3 |
|
20 | Update | 2016/10/17 20:31:03 | Recruitment status Last follow-up date Date of closure to data entry |
|
21 | Update | 2017/08/02 10:57:06 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
22 | Update | 2020/02/16 12:51:31 | Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |